Baader Bank Aktiengesellschaft Makes New Investment in Teleflex Incorporated $TFX

Baader Bank Aktiengesellschaft acquired a new stake in Teleflex Incorporated (NYSE:TFX) in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 32,733 shares of the medical technology company’s stock, valued at approximately $4,005,000. Baader Bank Aktiengesellschaft owned approximately 0.07% of Teleflex at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. Norges Bank purchased a new position in shares of Teleflex during the 2nd quarter valued at approximately $65,826,000. Thrivent Financial for Lutherans raised its position in Teleflex by 1,161.0% during the third quarter. Thrivent Financial for Lutherans now owns 550,449 shares of the medical technology company’s stock worth $67,353,000 after acquiring an additional 506,796 shares during the period. Qube Research & Technologies Ltd lifted its holdings in Teleflex by 100.1% during the second quarter. Qube Research & Technologies Ltd now owns 606,804 shares of the medical technology company’s stock valued at $71,821,000 after purchasing an additional 303,521 shares in the last quarter. Wedge Capital Management L L P NC purchased a new position in Teleflex during the third quarter valued at $26,929,000. Finally, Boston Partners grew its position in shares of Teleflex by 112.5% in the second quarter. Boston Partners now owns 380,933 shares of the medical technology company’s stock valued at $45,085,000 after purchasing an additional 201,652 shares during the period. 95.62% of the stock is owned by institutional investors and hedge funds.

Teleflex Trading Down 0.2%

Shares of Teleflex stock opened at $106.04 on Wednesday. The company has a debt-to-equity ratio of 0.67, a current ratio of 2.57 and a quick ratio of 1.53. The stock’s 50 day simple moving average is $114.82 and its 200-day simple moving average is $119.20. The stock has a market cap of $4.69 billion, a P/E ratio of -14.43, a P/E/G ratio of 1.38 and a beta of 0.92. Teleflex Incorporated has a 1-year low of $100.18 and a 1-year high of $180.58.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on TFX shares. Wells Fargo & Company reduced their price target on shares of Teleflex from $139.00 to $116.00 and set an “equal weight” rating for the company in a research report on Thursday, January 29th. Wall Street Zen lowered Teleflex from a “buy” rating to a “hold” rating in a research note on Saturday, November 15th. Needham & Company LLC raised Teleflex from a “hold” rating to a “buy” rating and set a $138.00 target price for the company in a report on Tuesday, January 27th. Weiss Ratings restated a “sell (d)” rating on shares of Teleflex in a research report on Monday, December 29th. Finally, Royal Bank Of Canada reaffirmed a “sector perform” rating and issued a $135.00 price target on shares of Teleflex in a research note on Wednesday, December 17th. Two research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $139.00.

About Teleflex

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.